09/2009 - Državni zavod za intelektualno vlasništvo

HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 16, 2009, 9, 3373 – 3601 3549
Podnositelj europske MKP Broj objave europske Naziv izuma
prijave patenta
prijave patenta
(71) (51) (97) (54)
Genentech, Inc., US C07D 239/94 (2006.01)
EP 2094672 * ARYLSULFONAMIDE COMPOUNDS
A61K 31/517 (2006.01)
A61P 43/00 (2006.01)
GENENTECH, INC., US C07K 16/28 (2006.01)
EP 2094732 * DR6 ANTIBODIES INHIBITING THE BINDING OF DR6
C07K 14/705 (2006.01)
TO APP, AND USES THEREOF IN TREATING
GENENTECH, INC., US C07K 16/36 (2006.01)
A61P 37/00 (2006.01)
A61P 27/02 (2006.01)
GENENTECH, INC., US C12N 15/63 (2006.01)
C12N 15/11 (2006.01)
GENENTECH, INC., US C07D 239/48 (2006.01)
A61K 31/506 (2006.01)
GENENTECH, INC., US C07D 471/04 (2006.01)
C07D 487/04 (2006.01)
A61K 31/407 (2006.01)
A61P 29/00 (2006.01)
A61P 35/00 (2006.01)
GENENTECH, INC., US C07K 16/28 (2006.01)
C12N 15/13 (2006.01)
C12N 5/12 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
Genentech, Inc., US C12N 15/85 (2006.01)
C07K 14/71 (2006.01)
A01K 67/027 (2006.01)
G01N 33/68 (2006.01)
Georgia-Pacific France, FR A47K 10/38 (2006.01)
Georgia-Pacific France, FR A47K 10/16 (2006.01)
EP 2097455 *
EP 2097530 *
EP 2099771 *
EP 2099796 *
EP 2099827 *
EP 2099920 *
EP 2086379 *
EP 2094137 *
Giles-Komarx, Jill, US C12N 5/16 (2006.01)
C12N 15/02 (2006.01)
EP 2087102 *
Glaxo Group Limited, GB A61P 25/18 (2006.01)
C07D 471/04 (2006.01)
EP 2086643 *
C07D 491/052 (2006.01)
A61K 31/416 (2006.01)
A61K 31/4162 (2006.01)
Glaxo Group Limited, GB C07D 231/56 (2006.01)
C07D 401/10 (2006.01)
EP 2086942 *
C07D 403/10 (2006.01)
C07D 405/12 (2006.01)
C07D 409/12 (2006.01)
C07D 413/12 (2006.01)
A61K 31/4196 (2006.01)
A61K 31/502 (2006.01)
A61P 29/00 (2006.01)
Glaxo Group Limited, GB A61K 8/04 (2006.01)
A61K 8/25 (2006.01)
EP 2091501 *
A61K 8/73 (2006.01)
A61K 8/81 (2006.01)
A61Q 11/00 (2006.01)
Glaxo Group Limited, GB A61K 31/502 (2006.01)
EP 2091538 *
Glaxo Group Limited, GB A61M 15/00 (2006.01)
B65H 26/00 (2006.01)
G11B 15/32 (2006.01)
A61J 1/03 (2006.01)
A61J 7/00 (2006.01)
Glaxo Group Limited, GB C07D 413/04 (2006.01)
C07D 413/14 (2006.01)
A61K 31/405 (2006.01)
A61P 37/00 (2006.01)
Glaxo Group Limited, GB C07D 413/10 (2006.01)
C07D 413/14 (2006.01)
A61K 31/4245 (2006.01)
A61P 37/00 (2006.01)
Glaxo Group Limited, GB C07D 209/52 (2006.01)
A61K 31/403 (2006.01)
A61P 25/18 (2006.01)
Glaxo Group Limited, GB C07D 401/12 (2006.01)
C07D 401/14 (2006.01)
C07D 487/08 (2006.01)
A61K 31/496 (2006.01)
EP 2091602 *
EP 2091949 *
EP 2091950 *
EP 2094657 *
EP 2094686 *
NEUROLOGICAL DISORDERS
HUMANIZED ANTI-FACTOR D ANTIBODIES
COMPOSITIONS AND METHODS FOR THE
EXPRESSION OF NUCLEIC ACIDS
PYRIMIDINE KINASE INHIBITORS
AZA-INDOLYL COMPOUNDS AND METHODS OF
USE
ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND
THEIR USE IN THE PREVENTION AND TREATMENT
OF NOTCH3-RELATED DISEASES
TRANSGENIC MICE EXPRESSING HUMANIZED
VEGF
DISPENSER FOR ROLLED PAPER SHEETS
CONTAINING CELLULOSE WADDING
METHOD, MANUFACTURING DEVICE AND RELATED
ROLLS MADE OF SHEETS WITH ALTERNATING
CUTS AND PRECUTS
ENHANCEMENT OF HYBRIDOMA FUSION
EFFICIENCIES THROUGH CELL SYNCHRONIZATION
COMPOUNDS WHICH POTENTIATE AMPA
RECEPTOR AND USES THEREOF IN MEDICINE
NOVEL COMPOUNDS
NOVEL COMPOSITION
4-BENZYL-L(2H)-PHTHALAZINONES AS H1
RECEPTOR ANTAGONISTS
SHEET DRIVER FOR USE IN A DRUG DISPENSER
INDOLE DERIVATIVES AS S1P1 RECEPTOR
AGONISTS
OXADIAZOLE DERIVATIVES AS S1P1 RECEPTOR
AGONISTS
AZABICYCLIC COMPOUNDS AS SEROTONINE,
DOPAMINE AND NOREPINEPHRINE RE-UPTAKE
INHIBITORS
5-{2-[4-(2-METHYL-5-QUINOLINYL)-L-
PIPERIDINYL]ETHYL} QUINOLINONE DERIVATIVES
AS 5HT1A RECEPTOR MODULATORS FOR
TREATING SEXUAL DYSFUNCTION, COGNITION
IMPAIREMENT, PSYCHOTIC DISORDERS, ANXIETY,
DEPRESSION, ETC.
ISSN 1331-2030